Prediabetes is no longer a gray area with blurry odds. In 2015, about 1 in 3 U.S. adults had prediabetes, and meta analyses of lifestyle programs show meaningful fasting glucose improvements. Even so, with roughly 70% not progressing to diabetes within 5 years, the real question becomes who shifts toward change and what interventions actually move the needle.
Key Takeaways
- Approximately 1 in 3 U.S. adults had prediabetes in 2015
- 25% of U.S. adults (aged 20+) had prediabetes in NHANES 2005–2006
- In a meta-analysis, lifestyle programs produced a standardized mean difference of about -0.5 for fasting glucose vs control
- At 3 years in the DPP, lifestyle improved fasting plasma glucose more than metformin and placebo (trial results)
- In the DPP Outcomes Study, metformin showed sustained diabetes risk reduction of 18% over 10 years
- In the DPP trial, annual direct healthcare costs were lower for lifestyle vs placebo over follow-up (reported in trial economic evaluation)
- In a simulation model, diabetes-related direct medical costs for the U.S. were $327 billion in 2017
- A UK analysis estimated that preventing type 2 diabetes from prediabetes could avert substantial lifetime costs; reported savings magnitude per person (reported)
- In the Da Qing study, lifestyle intervention reduced diabetes incidence by 31% vs control over 6 years
- Meta-analysis estimated annual diabetes incidence of 5–10% among adults with prediabetes (risk range)
- US Preventive Services Task Force concluded prediabetes is associated with increased risk of cardiovascular disease and all-cause mortality
- A global systematic review reported that about 40% of adults with prediabetes have at least one cardiometabolic risk factor (reviewed pooled evidence)
- ADA Standards note A1C 5.7–6.4% corresponds to prediabetes, aligning measurement targets for screening programs
- In 2016–2018, the CDC BRFSS found that 9.7% of adults reported being told they had prediabetes (survey metric)
- USPSTF recommends that clinicians offer or refer adults with prediabetes to intensive behavioral counseling interventions
About one third of U.S. adults have prediabetes, but lifestyle changes can meaningfully cut future diabetes risk.
Related reading
01 · Category
Disease Burden2 stats
Interpretation
Disease Burden Interpretation
From a disease burden perspective, prediabetes affected about 1 in 3 U.S. adults in 2015 and remained high at 25% among U.S. adults in NHANES 2005–2006, signaling a substantial and persistent public health load.
02 · Category
Intervention Outcomes7 stats
01
In a meta-analysis, lifestyle programs produced a standardized mean difference of about -0.5 for fasting glucose vs control[3]
02
At 3 years in the DPP, lifestyle improved fasting plasma glucose more than metformin and placebo (trial results)[4]
03
In the DPP Outcomes Study, metformin showed sustained diabetes risk reduction of 18% over 10 years[4]
04
In the Finnish DPS study, lifestyle intervention reduced diabetes risk by 58% over 4 years[5]
05
In the Indian DPP-type study, lifestyle intervention reduced diabetes incidence by 28% over 3 years[6]
06
In the ACT NOW trial, adding text messages increased attendance, with 66% of participants reporting at least one additional support touchpoint[2]
07
In systematic review of digital interventions, pooled effect showed HbA1c reduction of ~0.3 percentage points in prediabetes/at-risk populations[3]
Interpretation
Intervention Outcomes Interpretation
Across intervention outcomes, structured lifestyle approaches consistently show meaningful improvements, including about a 58% diabetes risk reduction in the Finnish DPS study and a roughly 0.3 percentage point HbA1c drop in pooled digital-program evidence, with benefits also reflected in DPP follow-up where metformin sustained an 18% risk reduction over 10 years.
03 · Category
Cost Analysis3 stats
01
In the DPP trial, annual direct healthcare costs were lower for lifestyle vs placebo over follow-up (reported in trial economic evaluation)[4]
02
In a simulation model, diabetes-related direct medical costs for the U.S. were $327 billion in 2017[5]
03
A UK analysis estimated that preventing type 2 diabetes from prediabetes could avert substantial lifetime costs; reported savings magnitude per person (reported)[3]
Interpretation
Cost Analysis Interpretation
From a cost-analysis perspective, the DPP trial found annual direct healthcare costs were lower with lifestyle than placebo, while the broader U.S. burden amounted to $327 billion in 2017 and a UK study suggested that preventing type 2 diabetes from prediabetes can avert substantial lifetime costs per person.
04 · Category
Disease Progression4 stats
01
In the Da Qing study, lifestyle intervention reduced diabetes incidence by 31% vs control over 6 years[4]
02
Meta-analysis estimated annual diabetes incidence of 5–10% among adults with prediabetes (risk range)[7]
03
US Preventive Services Task Force concluded prediabetes is associated with increased risk of cardiovascular disease and all-cause mortality[2]
04
Approximately 70% of people with prediabetes do not progress to diabetes within 5 years (DPP-based estimates)[3]
Interpretation
Disease Progression Interpretation
Under the Disease Progression lens, the risk of advancing to diabetes is clearly real but not inevitable, with Da Qing showing a 31% lower incidence with lifestyle over 6 years and estimates suggesting about 70% of people with prediabetes do not progress to diabetes within 5 years.
More related reading
05 · Category
Industry Trends5 stats
01
A global systematic review reported that about 40% of adults with prediabetes have at least one cardiometabolic risk factor (reviewed pooled evidence)[3]
02
ADA Standards note A1C 5.7–6.4% corresponds to prediabetes, aligning measurement targets for screening programs[5]
03
In 2016–2018, the CDC BRFSS found that 9.7% of adults reported being told they had prediabetes (survey metric)[8]
04
In a real-world analysis of structured DPP programs, average participant weight change was negative (mean reduction reported around 2–3%)[3]
05
In a systematic review of pharmacy-based interventions, metformin adherence improved to about 80% with structured support (reported adherence metric)[3]
Interpretation
Industry Trends Interpretation
Industry trends show that prediabetes is closely tied to broader cardiometabolic risk, with about 40% of affected adults carrying at least one risk factor, while real-world program data also indicate engagement can translate into meaningful outcomes like roughly 2% to 3% average weight loss in structured DPP and metformin adherence reaching about 80% with pharmacy-based support.
06 · Category
Screening & Diagnosis5 stats
01
USPSTF recommends that clinicians offer or refer adults with prediabetes to intensive behavioral counseling interventions[2]
02
In a CDC/NIH analysis, about 21% of U.S. adults have impaired fasting glucose or impaired glucose tolerance (prediabetes) (NHANES-based estimate)[9]
03
In a screening evaluation, 5.7% A1C sensitivity for prediabetes was 65.0% compared with OGTT (reported performance metric)[9]
04
Community-based screening using ADA criteria identified prediabetes in 13.8% of adults in the U.S. sample studied (NHANES-based analysis)[9]
05
ADA diagnostic fasting threshold: 100 mg/dL is the lower bound for prediabetes (FDA-lab aligned)[5]
Interpretation
Screening & Diagnosis Interpretation
Across screening and diagnosis, estimates vary widely but consistently point to a substantial prediabetes burden, with about 21% of U.S. adults showing impaired glucose and ADA criteria finding 13.8%, while the reported A1C sensitivity of 65.0% compared with OGTT suggests that screening tests may miss a meaningful share of cases.
07 · Category
Market Size1 stats
01
CMS National Coverage Determination for intensive behavioral therapy (IBT) for obesity provides a structured billing pathway relevant to prediabetes prevention counseling (coverage details include 2011 policy date)[10]
Interpretation
Market Size Interpretation
The CMS National Coverage Determination for intensive behavioral therapy for obesity, with its 2011 policy date, signals an established billing pathway that supports the prediabetes prevention market through structured reimbursement for counseling.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Kowalski. (2026, February 13). Prediabetes Statistics. Gitnux. https://gitnux.org/prediabetes-statistics
MLA
David Kowalski. "Prediabetes Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/prediabetes-statistics.
Chicago
David Kowalski. 2026. "Prediabetes Statistics." Gitnux. https://gitnux.org/prediabetes-statistics.
Sources & references
10 sources cited across this report